SPC
BMEZ icon

Spirepoint Private Client’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Spirepoint Private Client’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Hold
10,436
– – 0.01% 326
2026
Q1 		$150K Buy
10,436
+197
+2% +$2.93K 0.01% 317
2025
Q4 		$154K Buy
+10,239
New +$154K 0.01% 306

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Spirepoint Private Client's BMEZ Position: Q2 2026 in Review

Spirepoint Private Client held its BlackRock Health Sciences Trust II (BMEZ) position steady in Q2 2026 at 10,436 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #326.

Spirepoint Private Client first reported a position in BMEZ in Q4 2025 and has held it in 3 quarters since. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Spirepoint Private Client held 10,436 shares of BlackRock Health Sciences Trust II worth $160K as of Q2 2026.
  • Spirepoint Private Client left its BlackRock Health Sciences Trust II share count unchanged in Q2 2026.
  • BlackRock Health Sciences Trust II made up 0.01% of Spirepoint Private Client's portfolio in Q2 2026, its #326 holding.
  • Spirepoint Private Client first reported a position in BlackRock Health Sciences Trust II in Q4 2025 and has held it in 3 quarters since.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.